We are live on ! Find out more
HR

Howe & Rusling Portfolio holdings

AUM $1.53B
1-Year Est. Return 21.45%
This Fund
S&P 500
This Quarter Est. Return
-3.12%
1 Year Est. Return
+21.45%
3 Year Est. Return
+66.11%
5 Year Est. Return
+83.74%
10 Year Est. Return
+259.21%
AUM
$847M
AUM Growth
-$46.4M
Cap. Flow
-$12.6M
Cap. Flow %
-1.49%
Top 10 Hldgs %
28.15%
Holding
348
New
16
Increased
131
Reduced
120
Closed
35

Top Buys

Rank Stock Value
1
ABBV icon
AbbVie
ABBV
+$8.3M
2
IUSG icon
iShares Core S&P US Growth ETF
IUSG
+$5.26M
3
TJX icon
TJX Companies
TJX
+$2.9M
4
AMT icon
American Tower
AMT
+$2.79M
5
DTE icon
DTE Energy
DTE
+$1.54M

Sector Composition

Rank Sector Weight
1 Technology 15.6%
2 Healthcare 10.94%
3 Financials 10.77%
4 Consumer Staples 8.64%
5 Energy 6.48%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DTE icon
26
DTE Energy
DTE
$29.1B
$10.1M 1.19%
101,408
+14,353
+16% +$1.54M
KO icon
27
Coca-Cola
KO
$374B
$9.33M 1.1%
166,731
+2,638
+2% +$158K
EOG icon
28
EOG Resources
EOG
$71.5B
$9.2M 1.09%
72,576
+3,376
+5% +$430K
GD icon
29
General Dynamics
GD
$104B
$9.04M 1.07%
40,890
-571
-1% -$126K
USHY icon
30
iShares Broad USD High Yield Corporate Bond ETF
USHY
$28.6B
$8.95M 1.06%
257,906
+5,734
+2% +$201K
RTX icon
31
RTX Corp
RTX
$300B
$8.86M 1.05%
123,151
-50,064
-29% -$4.29M
SPY icon
32
State Street SPDR S&P 500 ETF Trust
SPY
$819B
$8.82M 1.04%
20,634
-1,603
-7% -$713K
ABBV icon
33
AbbVie
ABBV
$435B
$8.76M 1.03%
58,783
+56,528
+2,507% +$8.3M
TXN icon
34
Texas Instruments
TXN
$254B
$8.71M 1.03%
54,781
-6,408
-10% -$1.09M
AZN icon
35
AstraZeneca
AZN
$250B
$8.68M 1.02%
64,107
-267
-0.4% -$36.5K
META icon
36
Meta Platforms (Facebook)
META
$1.5T
$8.4M 0.99%
27,968
+125
+0.4% +$37.7K
DOX icon
37
Amdocs
DOX
$5.87B
$7.84M 0.93%
92,768
+9,353
+11% +$845K
APH icon
38
Amphenol
APH
$212B
$7.4M 0.87%
176,272
+4,128
+2% +$178K
VYM icon
39
Vanguard High Dividend Yield ETF
VYM
$82.5B
$7.36M 0.87%
71,226
+8,282
+13% +$889K
CME icon
40
CME Group
CME
$95.2B
$7.17M 0.85%
35,806
+616
+2% +$122K
GPC icon
41
Genuine Parts
GPC
$18.1B
$6.87M 0.81%
47,571
+1,289
+3% +$200K
QCOM icon
42
Qualcomm
QCOM
$165B
$6.74M 0.8%
60,728
-967
-2% -$112K
UNP icon
43
Union Pacific
UNP
$176B
$6.68M 0.79%
32,798
+472
+1% +$103K
NEE icon
44
NextEra Energy
NEE
$179B
$6.58M 0.78%
114,851
-33,783
-23% -$2.34M
VO icon
45
Vanguard Morningstar Mid-Cap ETF
VO
$109B
$6.55M 0.77%
125,780
+2,644
+2% +$145K
V icon
46
Visa
V
$688B
$6.34M 0.75%
27,544
+687
+3% +$165K
VWO icon
47
Vanguard FTSE Emerging Markets ETF
VWO
$123B
$6.33M 0.75%
161,343
-9,067
-5% -$370K
BALL icon
48
Ball Corp
BALL
$16.9B
$6.28M 0.74%
126,138
+518
+0.4% +$28.3K
MDLZ icon
49
Mondelez International
MDLZ
$79.9B
$6.17M 0.73%
88,881
+1,901
+2% +$137K
MS icon
50
Morgan Stanley
MS
$343B
$6.03M 0.71%
73,792
-2,643
-3% -$229K

Similar funds

Howe & Rusling's Q3 2023 Portfolio in Review

As of Q3 2023, Howe & Rusling held 348 positions worth $847M, down 5.2% from $894M the previous quarter. Its ten largest holdings account for 28% of the portfolio.

Howe & Rusling's Q3 2023 filing shows 16 new, 131 increased, 120 reduced and 35 closed positions. Its largest new stake was Vanguard Mortgage-Backed Securities ETF: 5,672 shares worth $248K. The largest sale was Cigna, an estimated $6.78M.

By sector, the portfolio is most concentrated in Technology at 16% of assets, down from 16% a quarter earlier, followed by Healthcare and Financials.

  • Howe & Rusling's largest Q3 2023 buy was Vanguard Mortgage-Backed Securities ETF: 5,672 shares worth $248K.
  • Howe & Rusling added most to AbbVie in Q3 2023, an estimated $8.3M increase.
  • Howe & Rusling's biggest Q3 2023 reduction was Cigna, cutting an estimated $6.78M.
  • Howe & Rusling fully exited Live Nation Entertainment in Q3 2023, selling an estimated $1.71M.
  • Howe & Rusling's ten largest holdings make up 28% of its $847M portfolio in Q3 2023.
  • Howe & Rusling opened 16 new positions and closed 35 in Q3 2023.
  • Howe & Rusling's portfolio value fell 5.2% quarter-over-quarter to $847M.

Based on Howe & Rusling's 13F filing for Q3 2023, filed 9 Nov 2023.